1mg bpc 157 per day BPC-157 Dosing (Common Protocols), 🔹 Oral / Subcutaneous, • 500 mcg daily, • Duration: 6 weeks, 🔹 Intramuscular / Peritendinous, • 1 mg daily, • Duration: 6 weeks, ⚠️ Note:, Not approved by FDA or BPC 157 Dosage: A Doctor's

Muscle-Tendon Junction Research on injuries at the muscle-tendon junction (a common injury site in athletes) showed BPC-157 promoted coordinated healing of both tissue types, maintaining the integrity of this critical interface

For reasons of health and safety, the acquisition of ampoule openers may be necessary

Research investigations involving BPC-157 have examined its effects on nitric oxide (NO) synthase expression and NO-mediated signaling in vascular and mucosal tissue cell models, FAK-paxillin pathway involvement in cell migration assays, and VEGFR2 receptor activation dynamics in in vitro angiogenesis models

BPC-157, through its defense system, appears to counteract these systems and possibly reverse their over-activation and inhibition

Sikiric et al., 2016

Its FDA approval provides a level of clinical validation that few research peptides possess